Does OBINUTUZUMAB Cause Lymphoma? 94 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 94 reports of Lymphoma have been filed in association with OBINUTUZUMAB (Gazyva). This represents 0.7% of all adverse event reports for OBINUTUZUMAB.
94
Reports of Lymphoma with OBINUTUZUMAB
0.7%
of all OBINUTUZUMAB reports
22
Deaths
18
Hospitalizations
How Dangerous Is Lymphoma From OBINUTUZUMAB?
Of the 94 reports, 22 (23.4%) resulted in death, 18 (19.1%) required hospitalization, and 2 (2.1%) were considered life-threatening.
Is Lymphoma Listed in the Official Label?
Yes, Lymphoma is listed as a known adverse reaction in the official FDA drug label for OBINUTUZUMAB.
What Other Side Effects Does OBINUTUZUMAB Cause?
Off label use (1,584)
Neutropenia (1,276)
Febrile neutropenia (955)
Covid-19 (942)
Pyrexia (920)
Thrombocytopenia (889)
Disease progression (831)
Infusion related reaction (789)
Pneumonia (662)
Anaemia (640)
What Other Drugs Cause Lymphoma?
RANITIDINE (1,256)
RITUXIMAB (1,216)
ADALIMUMAB (982)
METHOTREXATE (861)
ETANERCEPT (697)
INFLIXIMAB (671)
CYCLOPHOSPHAMIDE (640)
LENALIDOMIDE (518)
PREDNISONE (490)
VINCRISTINE (422)
Which OBINUTUZUMAB Alternatives Have Lower Lymphoma Risk?
OBINUTUZUMAB vs OCELLA
OBINUTUZUMAB vs OCRELIZUMAB
OBINUTUZUMAB vs OCRIPLASMIN
OBINUTUZUMAB vs OCTINOXATE\OCTISALATE\ZINC
OBINUTUZUMAB vs OCTINOXATE\OCTOCRYLENE